421 related articles for article (PubMed ID: 34272095)
1. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
MacIntyre CR; Veness B; Berger D; Hamad N; Bari N
Vaccine; 2021 Aug; 39(34):4784-4787. PubMed ID: 34272095
[TBL] [Abstract][Full Text] [Related]
2. Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations.
Laffan MA; Rees S; Yadavalli M; Ferstenberg LB; Kumar Shankar N; Medin J; Foskett N; Arnold M; Gomes da Silva H; Bhuyan P; Nord M
Vaccine; 2022 Sep; 40(38):5585-5593. PubMed ID: 35989136
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada.
Procter TD; Ogasawara H; Spruin S; Wijayasri S; Abraham N; Blaser C; Hutchings K; Shaw A; Ogunnaike-Cooke S
Vaccine; 2023 Nov; 41(46):6802-6809. PubMed ID: 37806804
[TBL] [Abstract][Full Text] [Related]
4. Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data.
Lane S; Shakir S
Drug Saf; 2022 Sep; 45(9):1003-1008. PubMed ID: 35927605
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Sánchez van Kammen M; Aguiar de Sousa D; Poli S; Cordonnier C; Heldner MR; van de Munckhof A; Krzywicka K; van Haaps T; Ciccone A; Middeldorp S; Levi MM; Kremer Hovinga JA; Silvis S; Hiltunen S; Mansour M; Arauz A; Barboza MA; Field TS; Tsivgoulis G; Nagel S; Lindgren E; Tatlisumak T; Jood K; Putaala J; Ferro JM; Arnold M; Coutinho JM; ; Sharma AR; Elkady A; Negro A; Günther A; Gutschalk A; Schönenberger S; Buture A; Murphy S; Paiva Nunes A; Tiede A; Puthuppallil Philip A; Mengel A; Medina A; Hellström Vogel Å; Tawa A; Aujayeb A; Casolla B; Buck B; Zanferrari C; Garcia-Esperon C; Vayne C; Legault C; Pfrepper C; Tracol C; Soriano C; Guisado-Alonso D; Bougon D; Zimatore DS; Michalski D; Blacquiere D; Johansson E; Cuadrado-Godia E; De Maistre E; Carrera E; Vuillier F; Bonneville F; Giammello F; Bode FJ; Zimmerman J; d'Onofrio F; Grillo F; Cotton F; Caparros F; Puy L; Maier F; Gulli G; Frisullo G; Polkinghorne G; Franchineau G; Cangür H; Katzberg H; Sibon I; Baharoglu I; Brar J; Payen JF; Burrow J; Fernandes J; Schouten J; Althaus K; Garambois K; Derex L; Humbertjean L; Lebrato Hernandez L; Kellermair L; Morin Martin M; Petruzzellis M; Cotelli M; Dubois MC; Carvalho M; Wittstock M; Miranda M; Skjelland M; Bandettini di Poggio M; Scholz MJ; Raposo N; Kahnis R; Kruyt N; Huet O; Sharma P; Candelaresi P; Reiner P; Vieira R; Acampora R; Kern R; Leker R; Coutts S; Bal S; Sharma SS; Susen S; Cox T; Geeraerts T; Gattringer T; Bartsch T; Kleinig TJ; Dizonno V; Arslan Y
JAMA Neurol; 2021 Nov; 78(11):1314-1323. PubMed ID: 34581763
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
Li G; Cappuccini F; Marchevsky NG; Aley PK; Aley R; Anslow R; Bibi S; Cathie K; Clutterbuck E; Faust SN; Feng S; Heath PT; Kerridge S; Lelliott A; Mujadidi Y; Ng KF; Rhead S; Roberts H; Robinson H; Roderick MR; Singh N; Smith D; Snape MD; Song R; Tang K; Yao A; Liu X; Lambe T; Pollard AJ;
Lancet; 2022 Jun; 399(10342):2212-2225. PubMed ID: 35691324
[TBL] [Abstract][Full Text] [Related]
7. Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework.
Lau CL; Mayfield HJ; Sinclair JE; Brown SJ; Waller M; Enjeti AK; Baird A; Short KR; Mengersen K; Litt J
Vaccine; 2021 Dec; 39(51):7429-7440. PubMed ID: 34810000
[TBL] [Abstract][Full Text] [Related]
8. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study.
Tran HA; Deng L; Wood N; Choi P; Singleton S; Clarke L; Khanlari S; Maitland-Scott I; Bird R; Brown S; Manoharan B; Tan CW; Gold M; Hissaria P; Melody S; Chunilal S SD; Buttery J; Clothier H; Crawford NW; Phuong L; Pepperell D; Effler P; Parker C; Carter N; Macartney K; McStea M; Miller T; Nissen M; Larter C; Kay E; Chen VM
Lancet Reg Health West Pac; 2023 Nov; 40():100894. PubMed ID: 37701717
[TBL] [Abstract][Full Text] [Related]
10. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J
Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.
Lai CC; Ko WC; Chen CJ; Chen PY; Huang YC; Lee PI; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1027-1035. PubMed ID: 34176415
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system adverse events after ChAdOx1 vaccination.
Maramattom BV; Lotlikar RS; Sukumaran S
Neurol Sci; 2022 Jun; 43(6):3503-3507. PubMed ID: 35275317
[TBL] [Abstract][Full Text] [Related]
13. Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score.
Hwang J; Park SH; Lee SW; Lee SB; Lee MH; Jeong GH; Kim MS; Kim JY; Koyanagi A; Jacob L; Jung SY; Song J; Yon DK; Shin JI; Smith L
Eur Heart J; 2021 Oct; 42(39):4053-4063. PubMed ID: 34545400
[TBL] [Abstract][Full Text] [Related]
14. Fatal intracerebral haemorrhage associated with thrombosis with thrombocytopenia syndrome after ChAdOx1-S vaccine.
Gómez-Roldós A; González-Sánchez M; Vales-Montero M; Vázquez-Alen P; Fernández-Bullido Y; Iglesias-Mohedano AM; Díaz-Otero F; García-Pastor A; Gil-Núñez A
Rev Neurol; 2022 Oct; 75(7):199-202. PubMed ID: 36169326
[TBL] [Abstract][Full Text] [Related]
15. Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
Gordon SF; Clothier HJ; Morgan H; Buttery JP; Phuong LK; Monagle P; Chunilal S; Wood EM; Tran H; Szer J; Crawford NW;
Vaccine; 2021 Nov; 39(48):7052-7057. PubMed ID: 34756770
[TBL] [Abstract][Full Text] [Related]
16. Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review.
Waqar U; Ahmed S; Gardezi SMHA; Tahir MS; Abidin ZU; Hussain A; Ali N; Mahmood SF
Clin Appl Thromb Hemost; 2021; 27():10760296211068487. PubMed ID: 34907794
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data.
Cari L; Alhosseini MN; Fiore P; Pierno S; Pacor S; Bergamo A; Sava G; Nocentini G
J Autoimmun; 2021 Dec; 125():102742. PubMed ID: 34710832
[TBL] [Abstract][Full Text] [Related]
18. Aortic thrombosis and acute limb ischemia after ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccination: a case of vaccine-induced thrombocytopenia and thrombosis (VITT).
Vierstraete M; Sabbe T
Acta Chir Belg; 2023 Jun; 123(3):329-332. PubMed ID: 34890294
[TBL] [Abstract][Full Text] [Related]
19. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
[TBL] [Abstract][Full Text] [Related]
20. Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A cross-sectional study in six EU member states.
Buhl C; Jacobsen R; Almarsdóttir AB; Abtahi S; Andersen A; Deligianni E; Dermiki-Gkana F; Kontogiorgis C; Oikonomou C; Kursite M; Poplavska E; Hegger I; van der Goot M; Sousa Ferreira PB; Ribeiro-Vaz I; Silva AM; Kos M; Lipovec NČ; van Vliet E; Alves TL
Vaccine; 2024 Jan; 42(3):556-563. PubMed ID: 38182460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
